XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.140
+0.120 (3.97%)
Apr 2, 2025, 4:00 PM EDT - Market closed

XBiotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-38.53-24.56-32.9-17.41-11.22
Upgrade
Depreciation & Amortization
1.751.742.612.652.24
Upgrade
Stock-Based Compensation
1.753.265.064.4612.58
Upgrade
Other Operating Activities
5.53-1.892.8--
Upgrade
Change in Accounts Receivable
---4.11-4.11
Upgrade
Change in Accounts Payable
-0.360.090.36-0.51-0.33
Upgrade
Change in Unearned Revenue
-----4.5
Upgrade
Change in Income Taxes
-0.110.68.71-2.17-6.51
Upgrade
Change in Other Net Operating Assets
-0.992.09-0.6576.91-3.98
Upgrade
Operating Cash Flow
-30.96-18.73-14.8269.45-65.15
Upgrade
Capital Expenditures
-1.3-0.36-0.59-3.53-3.73
Upgrade
Investment in Securities
-61.86-63.31--
Upgrade
Investing Cash Flow
-1.361.5-63.89-3.53-3.73
Upgrade
Short-Term Debt Issued
10.25----
Upgrade
Total Debt Issued
10.25----
Upgrade
Net Debt Issued (Repaid)
10.25----
Upgrade
Issuance of Common Stock
0.20.01-810.28
Upgrade
Repurchase of Common Stock
-----420
Upgrade
Common Dividends Paid
----75-
Upgrade
Other Financing Activities
--0.01---
Upgrade
Financing Cash Flow
10.45-0.01--67.01-409.72
Upgrade
Foreign Exchange Rate Adjustments
-5.53-0.05-0.960.711.37
Upgrade
Net Cash Flow
-27.3542.72-79.68-0.38-477.23
Upgrade
Free Cash Flow
-32.27-19.09-15.4165.92-68.88
Upgrade
Free Cash Flow Margin
---384.26%358.38%-156.55%
Upgrade
Free Cash Flow Per Share
-1.06-0.63-0.512.19-2.23
Upgrade
Cash Interest Paid
0.4----
Upgrade
Cash Income Tax Paid
0.090.14--54.09
Upgrade
Levered Free Cash Flow
-26.29-16.1-6.3366-143.38
Upgrade
Unlevered Free Cash Flow
-25.79-16.1-6.3366-143.38
Upgrade
Change in Net Working Capital
1.44-2.7-8.14-78.09143.05
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q